SCNI · Scinai Immunotherapeutics Ltd.
Market Cap
$1.70M
Shares
677,581
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-26 | 2026-06-30 | |
| 6-K | 2026-08-19 | — | |
| 6-K | 2026-06-17 | — | |
| 6-K | 2026-06-15 | — | |
| 6-K | 2026-06-08 | — | |
| 6-K | 2026-05-12 | — | |
| 6-K | 2026-05-08 | 2025-12-31 | |
| 6-K | 2026-04-27 | — | |
| 20-F | 2026-04-01 | 2025-12-31 | |
| 6-K | 2026-03-23 | — | |
| 6-K | 2026-03-19 | — | |
| 6-K | 2026-02-25 | — | |
| 6-K | 2026-02-17 | — | |
| 6-K | 2025-12-23 | — | |
| 6-K | 2025-12-02 | — | |
| 6-K | 2025-11-13 | — | |
| 6-K | 2025-11-13 | — | |
| 6-K | 2025-10-06 | — | |
| 6-K | 2025-09-22 | — | |
| 6-K | 2025-09-11 | — | |
| 6-K | 2025-09-02 | 2025-06-30 | |
| 6-K | 2025-06-12 | — | |
| 6-K | 2025-06-05 | — | |
| 6-K | 2025-06-02 | — | |
| 20-F | 2025-05-07 | 2024-12-31 | |
| 6-K | 2025-03-27 | — | |
| 6-K | 2025-03-24 | — | |
| 6-K | 2025-03-05 | — | |
| 6-K | 2025-03-04 | — | |
| 6-K | 2024-11-25 | — | |
| 6-K | 2024-11-22 | — | |
| 6-K | 2024-10-15 | — | |
| 6-K | 2024-09-26 | — | |
| 6-K | 2024-09-09 | 2024-06-30 | |
| 6-K | 2024-08-29 | — | |
| 6-K | 2024-08-21 | — | |
| 6-K | 2024-08-20 | — | |
| 6-K | 2024-08-15 | — | |
| 6-K | 2024-08-13 | — | |
| 6-K | 2024-08-12 | — | |
| 6-K/A | 2024-08-07 | — | |
| 6-K | 2024-08-05 | — | |
| 6-K | 2024-07-15 | — | |
| 6-K | 2024-07-15 | — | |
| 6-K | 2024-07-08 | — | |
| 6-K | 2024-07-08 | — | |
| 6-K | 2024-07-08 | — | |
| 6-K | 2024-06-14 | — | |
| 6-K | 2024-06-13 | — | |
| 6-K | 2024-06-13 | — |
Showing 1–50 of 175 filings
Key facts
CIK
1611747
CUSIP
09073Q303
13F (30d)
11 filings
11 filers
Visit website
Investor relations